Structural and Functional Abnormalities in the Islets Isolated from Type 2 Diabetic Subjects

Diabetes

Volumn 53, Issue 3, 2004, Pages 624-632

  Deng, Shaoping ^a   Vatamaniuk, Marko ^a,b   Huang, Xiaolun ^a   Doliba, Nicolai ^a,b   Lian, Moh Moh ^a   Frank, Adam ^a   Velidedeoglu, Ergun ^a   Desai, Niraj M ^a   Koeberlein, Brigitte ^a   Wolf, Bryan ^c   Barker, Clyde F ^a   Naji, Ali ^a   Matschinsky, Franz M ^a,b   Markmann, James F ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY MASS; CADAVER DONOR; CELL FUNCTION; CELL ISOLATION; CELL STRUCTURE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN RELEASE; ISCHEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PATHOGENESIS; PRIORITY JOURNAL;

AGE OF ONSET; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MIDDLE AGED; ORGAN SIZE; PATIENT SELECTION; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 10744222060     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.3.624     Document Type: Article

References (39)

1. Zimmet P, Alberti KG, Shaw J: Global and societal implications of the diabetes epidemic. Nature 414:782-787, 2001
2. American Diabetes Association: Economic consequences of diabetes mellitus in the U. S. in 1997. Diabetes Care 21:296-309, 1998
3. Songer TJ: The economic costs of NIDDM. Diabetes Metab Rev 8:389-404, 1992
4. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M, Finnish Diabetes Prevention Study Group: Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350, 2001
5. LeRoith D: Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities. Am J Med 113 (Suppl. 6A):3S-11S, 2002
6. Cerasi E, Ependic S, Luft R: Dose-response relation between plasma-insulin and blood-glucose levels during oral glucose loads in prediabetic and diabetic subjects. Lancet 1:794-797, 1973
7. Meigs JB: Epidemiology of the insulin resistance syndrome. Curr Diabetes Reports 3:73-79, 2003
8. Porte D Jr, Kahn SE: β-Cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes 50:S160-S163, 2001
9. Cerasi E: Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible? Diabetologia 38:992-997, 1995
10. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110, 2003
11. Bell GI, Polonsky KS: Diabetes mellitus and genetically programmed defects in β-cell function. Nature 414:788-791, 2001
12. Cavaghan MK, Ehrmann DA, Polonsky KS: Interactions between insulin resistance and insulin secretion in the development of glucose intolerance. J Clin Invest 106:329-333, 2000
13. Kahn SE: The importance of β-cell failure in the development and progression of type 2 diabetes. J Clin Endocrinol Metab 86:4047-4058, 2001
14. Polonsky KS, Sturis J, Bell GI: Non-insulin dependent diabetes mellitus - a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777-776, 1996
15. Clark A, Jones LC, de Koning E, Hansen BC, Matthews DR: Decreased insulin secretion in type 2 diabetes: a problem of cellular mass or function? Diabetes 50 (Suppl. 1):S169-S171, 2001
16. Weir GC, Laybutt DR, Kaneto H, Bonner-Weir S, Sharma A: β-Cell adaptation and decompensation during the progression of diabetes. Diabetes 50 (Suppl. 1):S154-S159, 2001
17. Leahy JL, Cooper HE, Deal DA, Weir GC: Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion: a study in normal rats using chronic in vivo glucose infusions. J Clin Invest 77:908-915, 1986
18. Eizirik DL, Korbutt GS, Hellerstrom C: Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the beta-cell function. J Clin Invest 90:1263-1268, 1992
19. Makhlouf L, Duvivier-Kali VF, Bonner-Weir S, Dieperink H, Weir GC, Sayegh MH: Importance of hyperglycemia on the primary function of allogeneic islet transplants. Transplantation 76:657-664, 2003
20. Donath MY, Gross DJ, Cerasi E, Kaiser N: Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738-744, 1999
21. Clark A, Cooper GJ, Lewis CE, Morris JF, Willis AC, Reid KB, Turner RC: Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet 2:231-234, 1987
22. Rahier J, Goebbels RM, Henquin JC: Cellular composition of the human diabetic pancreas. Diabetologia 24:366-371, 1983
23. Guiot Y, Sempoux C, Moulin P, Rahier J: No decrease of the β-cell mass in type 2 diabetic patients. Diabetes 50 (Suppl. 1):S188, 2001
24. Bonner-Weir S: Islet growth and development in the adult. J Mol Endocrinol 24:297-302, 2000
25. Lin JM, Fabregat ME, Gomis R, Bergsten P: Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. Diabetes 51:988-993, 2002
26. Hsueh WA, Law RE: Cardiovascular risk continuum: implications of insulin resistance and diabetes. Am J Med 105:4S-14S, 1998
27. Ricordi C, Lacy PE: Scharp DW. Automated islet isolation from human pancreas. Diabetes 38 (Suppl. 1):140-142, 1989
28. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in patients with diabetes using glucocorticoid-free immunosuppression. N Engl J Med 343:230-238, 2000
29. Verchere C, D'Alessio D, Palmiter R, Weir G, Bonner-Weir S, Baskin D, Kahn S: Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. Proc Natl Acad Sci USA 93:3492-3496, 1996
30. Sakuraba H, Mizukami H, Yagihashi N, Wada R, Hanyu C, Yagihashi S: Reduced beta-cell mass and expression of oxidative stress-related DNA damage in the islet of Japanese type II diabetic patients. Diabetologia 45:85-96, 2002
31. Lingohr MK, Buettner R, Rhodes CJ: Pancreatic beta-cell growth and survival - a role in obesity-linked type 2 diabetes. Trends Mol Med 8:375-384, 2002
32. Markmann JF, Deng S, Huang X, Desai N, Velidedeoglu E, Liu C, Frank A, Markmann E, Palanjian M, Brayman K, Wolf B, Bell E, Vitamaniuk M, Doliba N, Matschinsky F, Barker C, Naji A: Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 237:741-750, 2003
33. Boker A, Rothenberg L, Hernandez C, Kenyon NS, Ricordi C, Alejandro R: Human islet transplantation: update. World J Surg 25:481-486, 2001
34. Robertson RP: Islet transplantation: travels up the learning curve. Curr Diabetes Reports 2:365-370, 2002
35. Hering BJ, Matsumoto I, Sawada T, Nakano M, Sakai T, Kandaswamy R, Sutherland DE: Impact of two-layer pancreas preservation on islet isolation and transplantation. Transplantation 74:1813-1816, 2002
36. Tsujimura T, Kuroda Y, Kin T, Avila JG, Rajotte RV, Korbutt GS, Ryan EA, Shapiro AM, Lakey JR: Human islet transplantation from pancreases with prolonged cold ischemia using additional preservation by the two-layer (UW solution/perfluorochemical) cold-storage method. Transplantation 74:1687-1691, 2002
37. Fraker CA, Alejandro R, Ricordi C: Use of oxygenated perfluorocarbon toward making every pancreas count. Transplantation 74:1811-1812, 2002
38. Markmann JF, Deng S, Desai NM, Huang X, Velidedeoglu E, Frank A, Liu C, Brayman KL, Wolf B, Bell E, Vitamaniuk M, Doliba N, Matschinsky F, Markmann E, Barker CF, Naji A: The use of non-heart-beating donors for isolated islet transplantation. Transplantation 75:1423-1429, 2003
39. Barker CF, Frangipane LG, Silvers WK: Islet transplantation in genetically determined diabetes. Ann Surg 186:401-410, 1977